Neuroone Medical Technologies (NMTC) FCF Margin Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1,716.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,833.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 192.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 261.00 |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn | -5,290.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,290.00 |
| Dec 31, 2025 | -11,473.00 |
| Sep 30, 2025 | 93,695.00 |
| Jun 30, 2025 | 19,878.00 |
| Mar 31, 2025 | 15,593.00 |
| Dec 31, 2024 | 39,905.00 |
| Sep 30, 2024 | -59,390.00 |
| Jun 30, 2024 | 20,126.00 |
| Mar 31, 2024 | 63,933.00 |
| Dec 31, 2023 | 266,450.00 |
| Sep 30, 2023 | -178,253.00 |
| Jun 30, 2023 | 790,718.00 |
| Mar 31, 2023 | 826,156.00 |
| Dec 31, 2022 | 506,291.00 |
| Sep 30, 2022 | 565,440.00 |
| Jun 30, 2022 | -261,163.00 |
| Mar 31, 2022 | 398,644.00 |
| Dec 31, 2021 | -545,663.00 |
| Mar 31, 2015 | -1.73 Mn |
| Jun 30, 2014 | 333,989.00 |
| Mar 31, 2014 | 72,007.00 |
| Mar 31, 2013 | 301,920.00 |
| Dec 31, 2012 | 482,499.00 |
| Sep 30, 2012 | -1.93 Mn |
| Mar 31, 2012 | -353,749.00 |